 | • レポートコード：MRC2-11QY12797 • 出版社/出版日：QYResearch / 2020年11月30日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、116ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は2型糖尿病のグローバル市場について調査・分析したレポートです。種類別（インスリン、DPP-4阻害剤、GLP-1受容体作動薬、SGLT-2阻害剤）市場規模、用途別（ドラッグストア、病院、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別2型糖尿病の競争状況、市場シェア ・世界の2型糖尿病市場：種類別市場規模 2015年-2020年（インスリン、DPP-4阻害剤、GLP-1受容体作動薬、SGLT-2阻害剤） ・世界の2型糖尿病市場：種類別市場規模予測 2021年-2026年（インスリン、DPP-4阻害剤、GLP-1受容体作動薬、SGLT-2阻害剤） ・世界の2型糖尿病市場：用途別市場規模 2015年-2020年（ドラッグストア、病院、その他） ・世界の2型糖尿病市場：用途別市場規模予測 2021年-2026年（ドラッグストア、病院、その他） ・北米の2型糖尿病市場分析：米国、カナダ ・ヨーロッパの2型糖尿病市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの2型糖尿病市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の2型糖尿病市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの2型糖尿病市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Novo Nordisk、Sanofi、Merck、Eli Lily、AstraZeneca、Astellas Pharma、Daiichi Sankyo、Biocon、Boehringer Ingelheim ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Type 2 diabetes is a progressive condition in which the body becomes resistant to the normal effects of insulin and/or gradually loses the capacity to produce enough insulin in the pancreas. We do not know what causes type 2 diabetes. Type 2 diabetes is associated with modifiable lifestyle risk factors. Type 2 diabetes also has strong genetic and family related risk factors.
The dramatic increase in the prevalence, progressive nature and diagnosis of type 2 diabetes is the main driver of this rapid growth rate. The rise in disease-related comorbidities has also fuelled a more aggressive approach to treatment, including the use of multiple-drug therapies.
Market Analysis and Insights: Global Type 2 Diabetes Market
The global Type 2 Diabetes market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Type 2 Diabetes Scope and Market Size
Type 2 Diabetes market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Type 2 Diabetes market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Type 2 Diabetes market is segmented into
Insulins
DPP-4 Inhibitors
GLP-1 Receptor Agonists
SGLT-2 Inhibitors
Segment by Application, the Type 2 Diabetes market is segmented into
Drugstore
Hospital
Others
Regional and Country-level Analysis
The Type 2 Diabetes market is analysed and market size information is provided by regions (countries).
The key regions covered in the Type 2 Diabetes market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Type 2 Diabetes Market Share Analysis
Type 2 Diabetes market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Type 2 Diabetes business, the date to enter into the Type 2 Diabetes market, Type 2 Diabetes product introduction, recent developments, etc.
The major vendors covered:
Novo Nordisk
Sanofi
Merck
Eli Lily
AstraZeneca
Astellas Pharma
Daiichi Sankyo
Biocon
Boehringer Ingelheim
1 Study Coverage
1.1 Type 2 Diabetes Product Introduction
1.2 Market Segments
1.3 Key Type 2 Diabetes Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Type 2 Diabetes Market Size Growth Rate by Type
1.4.2 Insulins
1.4.3 DPP-4 Inhibitors
1.4.4 GLP-1 Receptor Agonists
1.4.5 SGLT-2 Inhibitors
1.5 Market by Application
1.5.1 Global Type 2 Diabetes Market Size Growth Rate by Application
1.5.2 Drugstore
1.5.3 Hospital
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Type 2 Diabetes Market Size, Estimates and Forecasts
2.1.1 Global Type 2 Diabetes Revenue 2015-2026
2.1.2 Global Type 2 Diabetes Sales 2015-2026
2.2 Global Type 2 Diabetes, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Type 2 Diabetes Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Type 2 Diabetes Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Type 2 Diabetes Competitor Landscape by Players
3.1 Type 2 Diabetes Sales by Manufacturers
3.1.1 Type 2 Diabetes Sales by Manufacturers (2015-2020)
3.1.2 Type 2 Diabetes Sales Market Share by Manufacturers (2015-2020)
3.2 Type 2 Diabetes Revenue by Manufacturers
3.2.1 Type 2 Diabetes Revenue by Manufacturers (2015-2020)
3.2.2 Type 2 Diabetes Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Type 2 Diabetes Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Type 2 Diabetes Revenue in 2019
3.2.5 Global Type 2 Diabetes Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Type 2 Diabetes Price by Manufacturers
3.4 Type 2 Diabetes Manufacturing Base Distribution, Product Types
3.4.1 Type 2 Diabetes Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Type 2 Diabetes Product Type
3.4.3 Date of International Manufacturers Enter into Type 2 Diabetes Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Type 2 Diabetes Market Size by Type (2015-2020)
4.1.1 Global Type 2 Diabetes Sales by Type (2015-2020)
4.1.2 Global Type 2 Diabetes Revenue by Type (2015-2020)
4.1.3 Type 2 Diabetes Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Type 2 Diabetes Market Size Forecast by Type (2021-2026)
4.2.1 Global Type 2 Diabetes Sales Forecast by Type (2021-2026)
4.2.2 Global Type 2 Diabetes Revenue Forecast by Type (2021-2026)
4.2.3 Type 2 Diabetes Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Type 2 Diabetes Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Type 2 Diabetes Market Size by Application (2015-2020)
5.1.1 Global Type 2 Diabetes Sales by Application (2015-2020)
5.1.2 Global Type 2 Diabetes Revenue by Application (2015-2020)
5.1.3 Type 2 Diabetes Price by Application (2015-2020)
5.2 Type 2 Diabetes Market Size Forecast by Application (2021-2026)
5.2.1 Global Type 2 Diabetes Sales Forecast by Application (2021-2026)
5.2.2 Global Type 2 Diabetes Revenue Forecast by Application (2021-2026)
5.2.3 Global Type 2 Diabetes Price Forecast by Application (2021-2026)
6 North America
6.1 North America Type 2 Diabetes by Country
6.1.1 North America Type 2 Diabetes Sales by Country
6.1.2 North America Type 2 Diabetes Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Type 2 Diabetes Market Facts & Figures by Type
6.3 North America Type 2 Diabetes Market Facts & Figures by Application
7 Europe
7.1 Europe Type 2 Diabetes by Country
7.1.1 Europe Type 2 Diabetes Sales by Country
7.1.2 Europe Type 2 Diabetes Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Type 2 Diabetes Market Facts & Figures by Type
7.3 Europe Type 2 Diabetes Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Type 2 Diabetes by Region
8.1.1 Asia Pacific Type 2 Diabetes Sales by Region
8.1.2 Asia Pacific Type 2 Diabetes Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Type 2 Diabetes Market Facts & Figures by Type
8.3 Asia Pacific Type 2 Diabetes Market Facts & Figures by Application
9 Latin America
9.1 Latin America Type 2 Diabetes by Country
9.1.1 Latin America Type 2 Diabetes Sales by Country
9.1.2 Latin America Type 2 Diabetes Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Type 2 Diabetes Market Facts & Figures by Type
9.3 Central & South America Type 2 Diabetes Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Type 2 Diabetes by Country
10.1.1 Middle East and Africa Type 2 Diabetes Sales by Country
10.1.2 Middle East and Africa Type 2 Diabetes Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Type 2 Diabetes Market Facts & Figures by Type
10.3 Middle East and Africa Type 2 Diabetes Market Facts & Figures by Application
11 Company Profiles
11.1 Novo Nordisk
11.1.1 Novo Nordisk Corporation Information
11.1.2 Novo Nordisk Description and Business Overview
11.1.3 Novo Nordisk Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Novo Nordisk Type 2 Diabetes Products Offered
11.1.5 Novo Nordisk Related Developments
11.2 Sanofi
11.2.1 Sanofi Corporation Information
11.2.2 Sanofi Description and Business Overview
11.2.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Sanofi Type 2 Diabetes Products Offered
11.2.5 Sanofi Related Developments
11.3 Merck
11.3.1 Merck Corporation Information
11.3.2 Merck Description and Business Overview
11.3.3 Merck Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Merck Type 2 Diabetes Products Offered
11.3.5 Merck Related Developments
11.4 Eli Lily
11.4.1 Eli Lily Corporation Information
11.4.2 Eli Lily Description and Business Overview
11.4.3 Eli Lily Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Eli Lily Type 2 Diabetes Products Offered
11.4.5 Eli Lily Related Developments
11.5 AstraZeneca
11.5.1 AstraZeneca Corporation Information
11.5.2 AstraZeneca Description and Business Overview
11.5.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
11.5.4 AstraZeneca Type 2 Diabetes Products Offered
11.5.5 AstraZeneca Related Developments
11.6 Astellas Pharma
11.6.1 Astellas Pharma Corporation Information
11.6.2 Astellas Pharma Description and Business Overview
11.6.3 Astellas Pharma Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Astellas Pharma Type 2 Diabetes Products Offered
11.6.5 Astellas Pharma Related Developments
11.7 Daiichi Sankyo
11.7.1 Daiichi Sankyo Corporation Information
11.7.2 Daiichi Sankyo Description and Business Overview
11.7.3 Daiichi Sankyo Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Daiichi Sankyo Type 2 Diabetes Products Offered
11.7.5 Daiichi Sankyo Related Developments
11.8 Biocon
11.8.1 Biocon Corporation Information
11.8.2 Biocon Description and Business Overview
11.8.3 Biocon Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Biocon Type 2 Diabetes Products Offered
11.8.5 Biocon Related Developments
11.9 Boehringer Ingelheim
11.9.1 Boehringer Ingelheim Corporation Information
11.9.2 Boehringer Ingelheim Description and Business Overview
11.9.3 Boehringer Ingelheim Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Boehringer Ingelheim Type 2 Diabetes Products Offered
11.9.5 Boehringer Ingelheim Related Developments
11.1 Novo Nordisk
11.1.1 Novo Nordisk Corporation Information
11.1.2 Novo Nordisk Description and Business Overview
11.1.3 Novo Nordisk Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Novo Nordisk Type 2 Diabetes Products Offered
11.1.5 Novo Nordisk Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Type 2 Diabetes Market Estimates and Projections by Region
12.1.1 Global Type 2 Diabetes Sales Forecast by Regions 2021-2026
12.1.2 Global Type 2 Diabetes Revenue Forecast by Regions 2021-2026
12.2 North America Type 2 Diabetes Market Size Forecast (2021-2026)
12.2.1 North America: Type 2 Diabetes Sales Forecast (2021-2026)
12.2.2 North America: Type 2 Diabetes Revenue Forecast (2021-2026)
12.2.3 North America: Type 2 Diabetes Market Size Forecast by Country (2021-2026)
12.3 Europe Type 2 Diabetes Market Size Forecast (2021-2026)
12.3.1 Europe: Type 2 Diabetes Sales Forecast (2021-2026)
12.3.2 Europe: Type 2 Diabetes Revenue Forecast (2021-2026)
12.3.3 Europe: Type 2 Diabetes Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Type 2 Diabetes Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Type 2 Diabetes Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Type 2 Diabetes Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Type 2 Diabetes Market Size Forecast by Region (2021-2026)
12.5 Latin America Type 2 Diabetes Market Size Forecast (2021-2026)
12.5.1 Latin America: Type 2 Diabetes Sales Forecast (2021-2026)
12.5.2 Latin America: Type 2 Diabetes Revenue Forecast (2021-2026)
12.5.3 Latin America: Type 2 Diabetes Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Type 2 Diabetes Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Type 2 Diabetes Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Type 2 Diabetes Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Type 2 Diabetes Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Type 2 Diabetes Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Type 2 Diabetes Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Type 2 Diabetes Market Segments
Table 2. Ranking of Global Top Type 2 Diabetes Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Type 2 Diabetes Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of Insulins
Table 5. Major Manufacturers of DPP-4 Inhibitors
Table 6. Major Manufacturers of GLP-1 Receptor Agonists
Table 7. Major Manufacturers of SGLT-2 Inhibitors
Table 8. Global Type 2 Diabetes Market Size Growth Rate by Application 2020-2026 (K MT)
Table 9. Global Type 2 Diabetes Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 10. Global Type 2 Diabetes Sales by Regions 2015-2020 (K MT)
Table 11. Global Type 2 Diabetes Sales Market Share by Regions (2015-2020)
Table 12. Global Type 2 Diabetes Revenue by Regions 2015-2020 (US$ Million)
Table 13. Global Type 2 Diabetes Sales by Manufacturers (2015-2020) (K MT)
Table 14. Global Type 2 Diabetes Sales Share by Manufacturers (2015-2020)
Table 15. Global Type 2 Diabetes Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 16. Global Type 2 Diabetes by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Type 2 Diabetes as of 2019)
Table 17. Type 2 Diabetes Revenue by Manufacturers (2015-2020) (US$ Million)
Table 18. Type 2 Diabetes Revenue Share by Manufacturers (2015-2020)
Table 19. Key Manufacturers Type 2 Diabetes Price (2015-2020) (USD/MT)
Table 20. Type 2 Diabetes Manufacturers Manufacturing Base Distribution and Headquarters
Table 21. Manufacturers Type 2 Diabetes Product Type
Table 22. Date of International Manufacturers Enter into Type 2 Diabetes Market
Table 23. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 24. Global Type 2 Diabetes Sales by Type (2015-2020) (K MT)
Table 25. Global Type 2 Diabetes Sales Share by Type (2015-2020)
Table 26. Global Type 2 Diabetes Revenue by Type (2015-2020) (US$ Million)
Table 27. Global Type 2 Diabetes Revenue Share by Type (2015-2020)
Table 28. Type 2 Diabetes Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 29. Global Type 2 Diabetes Sales by Application (2015-2020) (K MT)
Table 30. Global Type 2 Diabetes Sales Share by Application (2015-2020)
Table 31. North America Type 2 Diabetes Sales by Country (2015-2020) (K MT)
Table 32. North America Type 2 Diabetes Sales Market Share by Country (2015-2020)
Table 33. North America Type 2 Diabetes Revenue by Country (2015-2020) (US$ Million)
Table 34. North America Type 2 Diabetes Revenue Market Share by Country (2015-2020)
Table 35. North America Type 2 Diabetes Sales by Type (2015-2020) (K MT)
Table 36. North America Type 2 Diabetes Sales Market Share by Type (2015-2020)
Table 37. North America Type 2 Diabetes Sales by Application (2015-2020) (K MT)
Table 38. North America Type 2 Diabetes Sales Market Share by Application (2015-2020)
Table 39. Europe Type 2 Diabetes Sales by Country (2015-2020) (K MT)
Table 40. Europe Type 2 Diabetes Sales Market Share by Country (2015-2020)
Table 41. Europe Type 2 Diabetes Revenue by Country (2015-2020) (US$ Million)
Table 42. Europe Type 2 Diabetes Revenue Market Share by Country (2015-2020)
Table 43. Europe Type 2 Diabetes Sales by Type (2015-2020) (K MT)
Table 44. Europe Type 2 Diabetes Sales Market Share by Type (2015-2020)
Table 45. Europe Type 2 Diabetes Sales by Application (2015-2020) (K MT)
Table 46. Europe Type 2 Diabetes Sales Market Share by Application (2015-2020)
Table 47. Asia Pacific Type 2 Diabetes Sales by Region (2015-2020) (K MT)
Table 48. Asia Pacific Type 2 Diabetes Sales Market Share by Region (2015-2020)
Table 49. Asia Pacific Type 2 Diabetes Revenue by Region (2015-2020) (US$ Million)
Table 50. Asia Pacific Type 2 Diabetes Revenue Market Share by Region (2015-2020)
Table 51. Asia Pacific Type 2 Diabetes Sales by Type (2015-2020) (K MT)
Table 52. Asia Pacific Type 2 Diabetes Sales Market Share by Type (2015-2020)
Table 53. Asia Pacific Type 2 Diabetes Sales by Application (2015-2020) (K MT)
Table 54. Asia Pacific Type 2 Diabetes Sales Market Share by Application (2015-2020)
Table 55. Latin America Type 2 Diabetes Sales by Country (2015-2020) (K MT)
Table 56. Latin America Type 2 Diabetes Sales Market Share by Country (2015-2020)
Table 57. Latin Americaa Type 2 Diabetes Revenue by Country (2015-2020) (US$ Million)
Table 58. Latin America Type 2 Diabetes Revenue Market Share by Country (2015-2020)
Table 59. Latin America Type 2 Diabetes Sales by Type (2015-2020) (K MT)
Table 60. Latin America Type 2 Diabetes Sales Market Share by Type (2015-2020)
Table 61. Latin America Type 2 Diabetes Sales by Application (2015-2020) (K MT)
Table 62. Latin America Type 2 Diabetes Sales Market Share by Application (2015-2020)
Table 63. Middle East and Africa Type 2 Diabetes Sales by Country (2015-2020) (K MT)
Table 64. Middle East and Africa Type 2 Diabetes Sales Market Share by Country (2015-2020)
Table 65. Middle East and Africa Type 2 Diabetes Revenue by Country (2015-2020) (US$ Million)
Table 66. Middle East and Africa Type 2 Diabetes Revenue Market Share by Country (2015-2020)
Table 67. Middle East and Africa Type 2 Diabetes Sales by Type (2015-2020) (K MT)
Table 68. Middle East and Africa Type 2 Diabetes Sales Market Share by Type (2015-2020)
Table 69. Middle East and Africa Type 2 Diabetes Sales by Application (2015-2020) (K MT)
Table 70. Middle East and Africa Type 2 Diabetes Sales Market Share by Application (2015-2020)
Table 71. Novo Nordisk Corporation Information
Table 72. Novo Nordisk Description and Major Businesses
Table 73. Novo Nordisk Type 2 Diabetes Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 74. Novo Nordisk Product
Table 75. Novo Nordisk Recent Development
Table 76. Sanofi Corporation Information
Table 77. Sanofi Description and Major Businesses
Table 78. Sanofi Type 2 Diabetes Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 79. Sanofi Product
Table 80. Sanofi Recent Development
Table 81. Merck Corporation Information
Table 82. Merck Description and Major Businesses
Table 83. Merck Type 2 Diabetes Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 84. Merck Product
Table 85. Merck Recent Development
Table 86. Eli Lily Corporation Information
Table 87. Eli Lily Description and Major Businesses
Table 88. Eli Lily Type 2 Diabetes Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 89. Eli Lily Product
Table 90. Eli Lily Recent Development
Table 91. AstraZeneca Corporation Information
Table 92. AstraZeneca Description and Major Businesses
Table 93. AstraZeneca Type 2 Diabetes Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 94. AstraZeneca Product
Table 95. AstraZeneca Recent Development
Table 96. Astellas Pharma Corporation Information
Table 97. Astellas Pharma Description and Major Businesses
Table 98. Astellas Pharma Type 2 Diabetes Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 99. Astellas Pharma Product
Table 100. Astellas Pharma Recent Development
Table 101. Daiichi Sankyo Corporation Information
Table 102. Daiichi Sankyo Description and Major Businesses
Table 103. Daiichi Sankyo Type 2 Diabetes Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 104. Daiichi Sankyo Product
Table 105. Daiichi Sankyo Recent Development
Table 106. Biocon Corporation Information
Table 107. Biocon Description and Major Businesses
Table 108. Biocon Type 2 Diabetes Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 109. Biocon Product
Table 110. Biocon Recent Development
Table 111. Boehringer Ingelheim Corporation Information
Table 112. Boehringer Ingelheim Description and Major Businesses
Table 113. Boehringer Ingelheim Type 2 Diabetes Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 114. Boehringer Ingelheim Product
Table 115. Boehringer Ingelheim Recent Development
Table 116. Global Type 2 Diabetes Sales Forecast by Regions (2021-2026) (K MT)
Table 117. Global Type 2 Diabetes Sales Market Share Forecast by Regions (2021-2026)
Table 118. Global Type 2 Diabetes Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 119. Global Type 2 Diabetes Revenue Market Share Forecast by Regions (2021-2026)
Table 120. North America: Type 2 Diabetes Sales Forecast by Country (2021-2026) (K MT)
Table 121. North America: Type 2 Diabetes Revenue Forecast by Country (2021-2026) (US$ Million)
Table 122. Europe: Type 2 Diabetes Sales Forecast by Country (2021-2026) (K MT)
Table 123. Europe: Type 2 Diabetes Revenue Forecast by Country (2021-2026) (US$ Million)
Table 124. Asia Pacific: Type 2 Diabetes Sales Forecast by Region (2021-2026) (K MT)
Table 125. Asia Pacific: Type 2 Diabetes Revenue Forecast by Region (2021-2026) (US$ Million)
Table 126. Latin America: Type 2 Diabetes Sales Forecast by Country (2021-2026) (K MT)
Table 127. Latin America: Type 2 Diabetes Revenue Forecast by Country (2021-2026) (US$ Million)
Table 128. Middle East and Africa: Type 2 Diabetes Sales Forecast by Country (2021-2026) (K MT)
Table 129. Middle East and Africa: Type 2 Diabetes Revenue Forecast by Country (2021-2026) (US$ Million)
Table 130. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 131. Key Challenges
Table 132. Market Risks
Table 133. Main Points Interviewed from Key Type 2 Diabetes Players
Table 134. Type 2 Diabetes Customers List
Table 135. Type 2 Diabetes Distributors List
Table 136. Research Programs/Design for This Report
Table 137. Key Data Information from Secondary Sources
Table 138. Key Data Information from Primary Sources
List of Figures
Figure 1. Type 2 Diabetes Product Picture
Figure 2. Global Type 2 Diabetes Sales Market Share by Type in 2020 & 2026
Figure 3. Insulins Product Picture
Figure 4. DPP-4 Inhibitors Product Picture
Figure 5. GLP-1 Receptor Agonists Product Picture
Figure 6. SGLT-2 Inhibitors Product Picture
Figure 7. Global Type 2 Diabetes Sales Market Share by Application in 2020 & 2026
Figure 8. Drugstore
Figure 9. Hospital
Figure 10. Others
Figure 11. Type 2 Diabetes Report Years Considered
Figure 12. Global Type 2 Diabetes Market Size 2015-2026 (US$ Million)
Figure 13. Global Type 2 Diabetes Sales 2015-2026 (K MT)
Figure 14. Global Type 2 Diabetes Market Size Market Share by Region: 2020 Versus 2026
Figure 15. Global Type 2 Diabetes Sales Market Share by Region (2015-2020)
Figure 16. Global Type 2 Diabetes Sales Market Share by Region in 2019
Figure 17. Global Type 2 Diabetes Revenue Market Share by Region (2015-2020)
Figure 18. Global Type 2 Diabetes Revenue Market Share by Region in 2019
Figure 19. Global Type 2 Diabetes Sales Share by Manufacturer in 2019
Figure 20. The Top 10 and 5 Players Market Share by Type 2 Diabetes Revenue in 2019
Figure 21. Type 2 Diabetes Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 22. Global Type 2 Diabetes Sales Market Share by Type (2015-2020)
Figure 23. Global Type 2 Diabetes Sales Market Share by Type in 2019
Figure 24. Global Type 2 Diabetes Revenue Market Share by Type (2015-2020)
Figure 25. Global Type 2 Diabetes Revenue Market Share by Type in 2019
Figure 26. Global Type 2 Diabetes Market Share by Price Range (2015-2020)
Figure 27. Global Type 2 Diabetes Sales Market Share by Application (2015-2020)
Figure 28. Global Type 2 Diabetes Sales Market Share by Application in 2019
Figure 29. Global Type 2 Diabetes Revenue Market Share by Application (2015-2020)
Figure 30. Global Type 2 Diabetes Revenue Market Share by Application in 2019
Figure 31. North America Type 2 Diabetes Sales Growth Rate 2015-2020 (K MT)
Figure 32. North America Type 2 Diabetes Revenue Growth Rate 2015-2020 (US$ Million)
Figure 33. North America Type 2 Diabetes Sales Market Share by Country in 2019
Figure 34. North America Type 2 Diabetes Revenue Market Share by Country in 2019
Figure 35. U.S. Type 2 Diabetes Sales Growth Rate (2015-2020) (K MT)
Figure 36. U.S. Type 2 Diabetes Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Canada Type 2 Diabetes Sales Growth Rate (2015-2020) (K MT)
Figure 38. Canada Type 2 Diabetes Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. North America Type 2 Diabetes Market Share by Type in 2019
Figure 40. North America Type 2 Diabetes Market Share by Application in 2019
Figure 41. Europe Type 2 Diabetes Sales Growth Rate 2015-2020 (K MT)
Figure 42. Europe Type 2 Diabetes Revenue Growth Rate 2015-2020 (US$ Million)
Figure 43. Europe Type 2 Diabetes Sales Market Share by Country in 2019
Figure 44. Europe Type 2 Diabetes Revenue Market Share by Country in 2019
Figure 45. Germany Type 2 Diabetes Sales Growth Rate (2015-2020) (K MT)
Figure 46. Germany Type 2 Diabetes Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. France Type 2 Diabetes Sales Growth Rate (2015-2020) (K MT)
Figure 48. France Type 2 Diabetes Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. U.K. Type 2 Diabetes Sales Growth Rate (2015-2020) (K MT)
Figure 50. U.K. Type 2 Diabetes Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Italy Type 2 Diabetes Sales Growth Rate (2015-2020) (K MT)
Figure 52. Italy Type 2 Diabetes Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Russia Type 2 Diabetes Sales Growth Rate (2015-2020) (K MT)
Figure 54. Russia Type 2 Diabetes Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Europe Type 2 Diabetes Market Share by Type in 2019
Figure 56. Europe Type 2 Diabetes Market Share by Application in 2019
Figure 57. Asia Pacific Type 2 Diabetes Sales Growth Rate 2015-2020 (K MT)
Figure 58. Asia Pacific Type 2 Diabetes Revenue Growth Rate 2015-2020 (US$ Million)
Figure 59. Asia Pacific Type 2 Diabetes Sales Market Share by Region in 2019
Figure 60. Asia Pacific Type 2 Diabetes Revenue Market Share by Region in 2019
Figure 61. China Type 2 Diabetes Sales Growth Rate (2015-2020) (K MT)
Figure 62. China Type 2 Diabetes Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Japan Type 2 Diabetes Sales Growth Rate (2015-2020) (K MT)
Figure 64. Japan Type 2 Diabetes Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. South Korea Type 2 Diabetes Sales Growth Rate (2015-2020) (K MT)
Figure 66. South Korea Type 2 Diabetes Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. India Type 2 Diabetes Sales Growth Rate (2015-2020) (K MT)
Figure 68. India Type 2 Diabetes Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Australia Type 2 Diabetes Sales Growth Rate (2015-2020) (K MT)
Figure 70. Australia Type 2 Diabetes Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Taiwan Type 2 Diabetes Sales Growth Rate (2015-2020) (K MT)
Figure 72. Taiwan Type 2 Diabetes Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Indonesia Type 2 Diabetes Sales Growth Rate (2015-2020) (K MT)
Figure 74. Indonesia Type 2 Diabetes Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Thailand Type 2 Diabetes Sales Growth Rate (2015-2020) (K MT)
Figure 76. Thailand Type 2 Diabetes Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Malaysia Type 2 Diabetes Sales Growth Rate (2015-2020) (K MT)
Figure 78. Malaysia Type 2 Diabetes Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Philippines Type 2 Diabetes Sales Growth Rate (2015-2020) (K MT)
Figure 80. Philippines Type 2 Diabetes Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Vietnam Type 2 Diabetes Sales Growth Rate (2015-2020) (K MT)
Figure 82. Vietnam Type 2 Diabetes Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Asia Pacific Type 2 Diabetes Market Share by Type in 2019
Figure 84. Asia Pacific Type 2 Diabetes Market Share by Application in 2019
Figure 85. Latin America Type 2 Diabetes Sales Growth Rate 2015-2020 (K MT)
Figure 86. Latin America Type 2 Diabetes Revenue Growth Rate 2015-2020 (US$ Million)
Figure 87. Latin America Type 2 Diabetes Sales Market Share by Country in 2019
Figure 88. Latin America Type 2 Diabetes Revenue Market Share by Country in 2019
Figure 89. Mexico Type 2 Diabetes Sales Growth Rate (2015-2020) (K MT)
Figure 90. Mexico Type 2 Diabetes Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Brazil Type 2 Diabetes Sales Growth Rate (2015-2020) (K MT)
Figure 92. Brazil Type 2 Diabetes Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Argentina Type 2 Diabetes Sales Growth Rate (2015-2020) (K MT)
Figure 94. Argentina Type 2 Diabetes Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Latin America Type 2 Diabetes Market Share by Type in 2019
Figure 96. Latin America Type 2 Diabetes Market Share by Application in 2019
Figure 97. Middle East and Africa Type 2 Diabetes Sales Growth Rate 2015-2020 (K MT)
Figure 98. Middle East and Africa Type 2 Diabetes Revenue Growth Rate 2015-2020 (US$ Million)
Figure 99. Middle East and Africa Type 2 Diabetes Sales Market Share by Country in 2019
Figure 100. Middle East and Africa Type 2 Diabetes Revenue Market Share by Country in 2019
Figure 101. Turkey Type 2 Diabetes Sales Growth Rate (2015-2020) (K MT)
Figure 102. Turkey Type 2 Diabetes Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. Saudi Arabia Type 2 Diabetes Sales Growth Rate (2015-2020) (K MT)
Figure 104. Saudi Arabia Type 2 Diabetes Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. U.A.E Type 2 Diabetes Sales Growth Rate (2015-2020) (K MT)
Figure 106. U.A.E Type 2 Diabetes Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. Middle East and Africa Type 2 Diabetes Market Share by Type in 2019
Figure 108. Middle East and Africa Type 2 Diabetes Market Share by Application in 2019
Figure 109. North America Type 2 Diabetes Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 110. North America Type 2 Diabetes Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 111. Europe Type 2 Diabetes Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 112. Europe Type 2 Diabetes Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Asia Pacific Type 2 Diabetes Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 114. Asia Pacific Type 2 Diabetes Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Latin America Type 2 Diabetes Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 116. Latin America Type 2 Diabetes Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Middle East and Africa Type 2 Diabetes Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 118. Middle East and Africa Type 2 Diabetes Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Porter's Five Forces Analysis
Figure 120. Channels of Distribution
Figure 121. Distributors Profiles
Figure 122. Bottom-up and Top-down Approaches for This Report
Figure 123. Data Triangulation
Figure 124. Key Executives Interviewed
糖尿病用非インスリン療法の世界市場（～2026年） Market Analysis and Insights: Global Non-Insulin Therapies for Diabetes Market The global Non-Insulin Therapies for Diabetes market size is projected to reach US$ 32930 million by 2026, from US$ 30040 million in 2020, at a CAGR of 8.9%% during 2021-2026. Global Non-Insulin Therapies for Diabetes Sco…- 不適切管理2型糖尿病治療の世界市場（～2026年） Diabetes is a serious complex condition which can affect the entire body. Diabetes occurs due to inadequate secretion of insulin inside the pancreas. Insulin secreted by pancreas in hormone made by beta cell which is responsible for the conversion of glucose from food to energy. There are different …
- 糖尿病モニターの世界市場（～2026年） Diabetes mellitus is a chronic disease resulting from an inadequacy of insulin in the body. The condition causes either elevated blood-glucose concentrations, named as hyperglycaemia, or low glucose level known as hypoglycaemia. Monitoring glucose level is expected to prolong life expectancy as it e…
- 1型糖尿病の世界市場（～2026年） Type 1 diabetes is a form of diabetes mellitus in which very little or no insulin is produced by the pancreas. The global type 1 diabetes market is expected to grow modestly during the forecast period owing to growing incidence and prevalence of diabetes and cohesive government policies. Market Anal…
- 糖尿病治療の世界市場（～2026年） Diabetes Treatment is a important way to help manage the healthy ,easy to use and improve the way of the treatment of blood glucose monitoring system. As living standards improve, an increasing obesity, the Diabetes Treatment has improved people's living habits, disease control effect, is becoming m…